Al-Sharif et al. found that PRG4 can compete with hyaluronan for binding to CD44, and then attenuates the growth-supporting signaling function of this receptor in rheumatoid arthritis fibroblast-like synoviocytes stimulated with interleukin-1β or tumor necrosis factor alpha42. This evidence concerns the gene CD44 and rheumatoid arthritis.